218 related articles for article (PubMed ID: 32527234)
1. Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections.
Chen X; Hu TM; Zuo J; Wu H; Liu ZH; Zhan YX; Xia Y; Wang J; Wei W
BMC Ophthalmol; 2020 Jun; 20(1):225. PubMed ID: 32527234
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.
Li F; Sun M; Guo J; Ma A; Zhao B
Curr Eye Res; 2017 Aug; 42(8):1174-1178. PubMed ID: 28441077
[TBL] [Abstract][Full Text] [Related]
3. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.
Pichi F; Elbarky AM; Elhamaky TR
Int Ophthalmol; 2019 Jan; 39(1):145-153. PubMed ID: 29274022
[TBL] [Abstract][Full Text] [Related]
4. RANIBIZUMAB FOR MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION: One Initial Injection Versus Three Monthly Injections.
Miwa Y; Muraoka Y; Osaka R; Ooto S; Murakami T; Suzuma K; Takahashi A; Iida Y; Yoshimura N; Tsujikawa A
Retina; 2017 Apr; 37(4):702-709. PubMed ID: 27471827
[TBL] [Abstract][Full Text] [Related]
5. Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections.
Osaka R; Muraoka Y; Miwa Y; Manabe K; Kobayashi M; Takasago Y; Ooto S; Murakami T; Suzuma K; Iida Y; Tsujikawa A
Ophthalmologica; 2018; 239(1):27-35. PubMed ID: 28946138
[TBL] [Abstract][Full Text] [Related]
6. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial.
Song S; Yu X; Zhang P; Gu X; Dai H
BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639
[TBL] [Abstract][Full Text] [Related]
7. Comparing ranibizumab, dexamethasone implant, and combined therapy for macular edema secondary to branch retinal vein occlusion: a clinical trial.
Meng L; Yang M; Jiang X; Li Y; Han X
Int Ophthalmol; 2024 Jun; 44(1):262. PubMed ID: 38913192
[TBL] [Abstract][Full Text] [Related]
8. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
Tang F; Qin X; Lu J; Song P; Li M; Ma X
Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
[TBL] [Abstract][Full Text] [Related]
9. Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ahn SJ; Ahn J; Woo SJ; Park KH
Biomed Res Int; 2013; 2013():209735. PubMed ID: 24066287
[TBL] [Abstract][Full Text] [Related]
10. Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept.
Zhang Q; Hou Y; Cao X; Zhang R; Liu Y; Wei C; Wu C; Mei L; Zhang P
BMC Ophthalmol; 2021 Nov; 21(1):402. PubMed ID: 34809591
[TBL] [Abstract][Full Text] [Related]
11. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.
Song W; Jiao W; Li F; Ma A; Zhao B
Biomed Res Int; 2020; 2020():9046781. PubMed ID: 32685542
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Ranibizumab in Asian Patients with Branch Retinal Vein Occlusion: Results from the Randomized BLOSSOM Study.
Wei W; Weisberger A; Zhu L; Cheng Y; Liu C;
Ophthalmol Retina; 2020 Jan; 4(1):57-66. PubMed ID: 31902472
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
Kim M; Jeong S; Sagong M
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion.
Son BK; Kwak HW; Kim ES; Yu SY
Korean J Ophthalmol; 2017 Jun; 31(3):209-216. PubMed ID: 28471106
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study.
Heier JS; Clark WL; Boyer DS; Brown DM; Vitti R; Berliner AJ; Kazmi H; Ma Y; Stemper B; Zeitz O; Sandbrink R; Haller JA
Ophthalmology; 2014 Jul; 121(7):1414-1420.e1. PubMed ID: 24679444
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anti-VEGF results between non-ischemic branch retinal vein occlusion and ischemic branch retinal vein occlusion with early sector panretinal photocoagulation.
Akdemir SC; Gunay BO
J Fr Ophtalmol; 2022 Nov; 45(9):1042-1047. PubMed ID: 36127168
[TBL] [Abstract][Full Text] [Related]
19. Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.
Winterhalter S; Eckert A; Vom Brocke GA; Schneider A; Pohlmann D; Pilger D; Joussen AM; Rehak M; Grittner U
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):267-279. PubMed ID: 29185099
[TBL] [Abstract][Full Text] [Related]
20. Aflibercept Treatment for Macular Edema following Branch Retinal Vein Occlusion: Age-Based Responses.
Sırakaya E; Küçük B; Ağadayı A
Ophthalmologica; 2020; 243(2):94-101. PubMed ID: 31461723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
